Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand? by Lucas C Godoy, Michael E Farkouh

Get full text

COVID‐19: a pandemic experience that illuminates potential reforms to health research by Hannah N Kozlowski, Michael E Farkouh, Meredith S Irwin, Laszlo G Radvanyi, Aaron D Schimmer, Uri Tabori, Norman D Rosenblum

Get full text

Body Mass Index, Comorbidities, and Ambulatory Care Visits: The REGARDS Study by Emily B. Levitan, Aowen Zhu, Vera Bittner, Todd M. Brown, Michael E. Farkouh, Mariam Girguis, Lei Huang, Elizabeth A. Jackson, Suzanne E. Judd, Shannon Rhodes, Monika M. Safford, Jennifer L. Strande, Min‐Jung Wang, Mark Woodward, D. Leann Long

Get full text

Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study by Douglas S Lee, Peter C Austin, Michael E Farkouh, Cynthia A Jackevicius, Jeffrey C Kwong, Bing Yu, Heather Ross, Jiming Fang, Joan Porter, Vladimír Džavík, Alanna Weisman, Andrea S Gershon, Wade Thompson, Jacob A Udell, Clare L Atzema, Laura E Ferreira-Legere, Andrew Ha

Get full text

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex by David Bobrowski, MD, Husam Abdel-Qadir, MD, PhD, Candace D. McNaughton, MD, PhD, MPH, Anna Chu, MHSc, Xuesong Wang, MSc, Peter C. Austin, PhD, Barbara S. Doumouras, MD, Karem Abdul-Samad, BSc, Peter A. Kavsak, PhD, Michael E. Farkouh, MD, MSc, James L. Januzzi, MD, Heather J. Ross, MHSc, MD, Douglas S. Lee, MD, PhD

Get full text

Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEART by Wade Thompson, PharmD, PhD, Brendan Wong, MD, Atul Sivaswamy, MSc, Laura Ferreira-Legere, MScN, Douglas S. Lee, MD, PhD, Husam Abdel-Qadir, MD, PhD, Dennis T. Ko, MD, MSc, Alanna Weisman, MD, PhD, Sheldon Tobe, MD, MSc, Cynthia A. Jackevicius, PharmD, MSc, Shaun G. Goodman, MD, MSc, Michael E. Farkouh, MD, Jacob A. Udell, MD, MPH

Get full text

Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial by Sylvain A. Lother, Wen Teng, Olawale Ayilara, Brett L. Houston, Barret Rush, Srinivas Murthy, Jose C. Nicolau, Lindsay Bond, Alexis F. Turgeon, John C. Marshall, Jonathan Paul, Judith S. Hochman, Matthew D. Neal, Michael E. Farkouh, Joel Nkosi, Donald S. Houston, Charlotte A. Bradbury, Asher A. Mendelson, Ewan C. Goligher, Allan Garland, Robert Balshaw, Souradet Y. Shaw, Patrick R. Lawler, Yoav Keynan, Ryan Zarychanski

Get full text

Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study by Rachel M. Wald, George Tomlinson, Christopher A. Caldarone, Nagib Dahdah, Frederic Dallaire, Christian Drolet, Michael E. Farkouh, Jasmine Grewal, Camille Hancock‐Friesen, Edward J. Hickey, Gauri Rani Karur, Michelle Keir, Adrienne H. Kovacs, Benedetta Leonardi, Brian W. McCrindle, Syed Najaf Nadeem, Ming‐Yen Ng, Michelle Samuel, Ashish Shah, Edythe B. Tham, Judith Therrien, Alexander Van De Bruaene, Isabelle F. Vonder Muhll, Andrew E. Warren, Kenichiro Yamamura, Paul Khairy

Get full text